On ECHEMI
Home > Drugs > Compound diisopropylamine dichloroacetate for injection

Compound diisopropylamine dichloroacetate for injection

Function and Efficacy

1. Effects on fatty liver (1) Consuming liver fat: This product is decomposed into diisopropylamine and dichloroacetic acid in the body. The former generates methionine under the activation of ATP, and the latter is metabolized to glycine. Under the action of glycine lyase, N5N10-CH2-FH4 (methyltetrahydrofolate) is generated, which provides energy at the same time. Both can provide methyl groups to promote choline synthesis. Choline reacts with liver fat to generate lecithin, which promotes the decomposition of liver fat. (2) Transporting liver fat: Lecithin, liver fat, and cholesterol combine with apolipoproteins to form lipoproteins. Lipoproteins are easily soluble in plasma, thereby transporting fat from the liver to the outside of the liver and reducing the accumulation of fat in the liver. (3) This product can reduce arterial blood

Ingredients

This product is a compound preparation of diisopropylamine dichloroacetate and sodium gluconate, and its composition is: each bottle contains 40 mg of diisopropylamine dichloroacetate and 38 mg of sodium gluconate.

Name Description Content CAS NO. Manufacturer
Diisopropylammonium dichloroacetateIngredients

It is broken down into diisopropylamine and dichloroacetic acid in the body. The former produces methionine, and the latter is metabolized to glycine. Under the action of glycine lyase, it produces N5N10-CH2-FH4 (methyltetrahydrofolate), which also provides energy and methyl to promote choline synthesis. Choline reacts with liver fat to produce lecithin, which promotes the decomposition of liver fat. It participates in the formation of lipoproteins and reduces fat accumulation in the liver.

More
660-27-5 14
Sodium gluconateIngredients

No specific pharmacological effects were mentioned.

More
527-07-1 12

Indication

Liver-protecting medicine. Used for fatty liver, intrahepatic cholestasis, and general liver dysfunction. Used for acute and chronic hepatitis, hepatomegaly, and early cirrhosis.

Usage and Dosage

Intramuscular injection: 40 mg (one vial) at a time, 1 to 2 times a day, dissolved in an appropriate amount of water for injection. Intravenous injection: 40 mg (one vial) at a time, 1 to 2 times a day, dissolved in an appropriate amount of water for injection. Intravenous drip: 40 to 80 mg (1 to 2 vials) at a time, 1 to 2 times a day, dissolved in an appropriate amount of water for injection, and diluted to an appropriate amount (50 ml to 100 ml) with 5% or 10% glucose injection or 0.9% sodium chloride injection. Please follow the doctor's advice for the course of treatment.

Adverse Reactions

Occasionally, you may experience dizziness, thirst, loss of appetite, etc., but these symptoms may disappear on their own.

Precautions

People who are allergic to this product are prohibited from using it. If an allergic reaction occurs, the symptoms will disappear after stopping the drug.

Drug Interactions

There are no special contraindications.

Storage

Keep away from light and store in a sealed container.

Packaging Specification

Each vial contains 40mg of diisopropylamine dichloroacetate and 38mg of sodium gluconate

Manufacturer

Jiangsu Huatai Chenguang Pharmaceutical Co., Ltd.

  • Founded in:

    2010-07-30
  • Address:

    Building 17, No. 12, Xinglin Road, Taizhou City
  • Tax NO.:

    913212915592502469
  • Registered Funds:

    90.350805 yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.